Haemonetics appoints Maryanne Farris as VP, Chief Accounting Officer; GC Michelle Basil continues

HAEMONETICS CORP

Maryanne Farris joined as VP, Chief Accounting Officer and principal accounting officer on Oct 17, 2022.
James D'Arecca remains EVP, CFO and principal financial officer; no change in his role.
Company and EVP/GC Michelle Basil mutually agreed to terminate a June 2022 transition letter; she continues in her current role.
Ms. Farris previously served as Chief Accountant at Azenta, Inc. and is a CPA.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Maryanne Farris

Vice President, Chief Accounting Officer

HAE · HAEMONETICS CORP

Effective: 2022-10-17
Filed: October 19, 2022, 7:59 PM ET

Ms. Farris, age 47, joined the Company as Vice President, Chief Accounting Officer on October 17, 2022.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Maryanne Farris was appointed as Vice President, Chief Accounting Officer at HAEMONETICS CORP.

Action: appointed
Role: Vice President, Chief Accounting Officer

Exact text from the filing

Ms. Farris, age 47, joined the Company as Vice President, Chief Accounting Officer on October 17, 2022.

View on SEC.gov

HAEMONETICS CORP filing history →

Source: SEC EDGAR

accession 0000313143-22-000056

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.